68Ga-PSMA与18F-FDG PET/CT在上皮样血管内皮瘤评估中的比较
一例32岁男性上皮样血管内皮瘤患者,随访18F-FDG PET/CT发现进展后,行68Ga-PSMA PET/CT评估177Lu-PSMA放射性核素治疗的潜力。肝病灶FDG SUVmax低,病灶-本底比(TBR)为5.1/2.9;68Ga-PSMA PET/CT显示中等PSMA SUVmax,TBR为4.5/1.1。作者认为,本病例中上皮样血管内皮瘤中等TBR的68Ga-PSMA可能对177Lu-PSMA放射性核素治疗有前景。
要点
- 上皮样血管内皮瘤肝病灶18F-FDG PET/CT显示低FDG SUVmax,TBR为5.1/2.9。
- 68Ga-PSMA PET/CT显示中等PSMA SUVmax,TBR为4.5/1.1。
- 作者认为中等TBR的68Ga-PSMA可能对177Lu-PSMA放射性核素治疗有前景。
核心结论
- 本病例报告表明,上皮样血管内皮瘤中68Ga-PSMA呈中等TBR,可能对177Lu-PSMA放射性核素治疗有前景。
研究设计与样本
- 本研究报告一例32岁男性上皮样血管内皮瘤患者的病例报告,在随访18F-FDG PET/CT观察到进展表现后行68Ga-PSMA PET/CT评估177Lu-PSMA放射性核素治疗的潜力。
主要发现
- 肝病灶18F-FDG PET/CT显示低FDG SUVmax,病灶-本底比(TBR)计算为5.1/2.9。
- 68Ga-PSMA PET/CT显示中等PSMA SUVmax,TBR计算为4.5/1.1。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 32-year-old man with epithelioid hemangioendothelioma was imaged with 68 Ga-PSMA PET/CT to evaluate the potential of 177 Lu-PSMA radionuclide therapy after progression findings were observed on follow-up 18 F-FDG PET/CT imaging. Liver lesions showed low FDG SUV max . The lesion-to-background ratio (TBR) was calculated as 5.1/2.9 on 18 F-FDG PET/CT imaging. However, 68 Ga-PSMA PET/CT showed moderate PSMA SUV max . TBR was calculated as 4.5/1.1. In conclusion, in this case report, we demonstrated that 68 Ga-PSMA with moderate TBR in epithelioid hemangioendothelioma may be promising for 177 Lu-PSMA radionuclide therapy.
引用
- Şenses V, Kaplan İ, Kaya F, et al. 68 Ga-PSMA Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma. Clin Nucl Med. 2024. PMID: 38861414. doi:10.1097/RLU.0000000000005333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。